TuHURA BIOSCIENCES, INC./NV Costs and Expenses
TuHURA BIOSCIENCES, INC./NV (HURA) reported Costs and Expenses of $10.92 thousand for the 3-month period ending 2011-12-31, per its 10-Q filed 2012-02-07.
Discontinued › Expense Statement › Operating Expenses
us-gaap:CostsAndExpenses · last filed 2012-02-07
- TuHURA BIOSCIENCES, INC./NV costs and expenses for the quarter ending 2011-12-31 was $10.92K, a 25.07% decline year-over-year.
- TuHURA BIOSCIENCES, INC./NV costs and expenses for the quarter ending 2011-09-30 was $3.86K, a 51.23% decline year-over-year.
- TuHURA BIOSCIENCES, INC./NV costs and expenses for the quarter ending 2010-12-31 was $14.57K.
- TuHURA BIOSCIENCES, INC./NV costs and expenses for the quarter ending 2010-09-30 was $7.91K.
| Period end | Costs and Expenses 3 month | Costs and Expenses 6 month | Costs and Expenses 27 month | Costs and Expenses 30 month |
|---|---|---|---|---|
| 2011-12-31 | $10.92K 10-Q · filed 2012-02-07 | $14.77K 10-Q · filed 2012-02-07 | $53.49K 10-Q · filed 2012-02-07 | |
| 2011-09-30 | $3.86K 10-Q · filed 2011-11-10 | $42.58K 10-Q · filed 2011-11-10 | ||
| 2010-12-31 | $14.57K 10-Q · filed 2012-02-07 | $22.48K 10-Q · filed 2012-02-07 | ||
| 2010-09-30 | $7.91K 10-Q · filed 2011-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |